Dr. Fei Tian

Dr. Fei Tian has a diverse work experience spanning various roles in the finance and healthcare sectors. Dr. Fei started their career as an Assistant Doctor at Shanghai Tongji Hospital from September 2004 to August 2007. Dr. Fei then worked as a Researcher at the University Hospital of Ludwig-Maximilian University Munich from August 2008 to December 2011. Dr. Tian later joined Novumed LLC as an Analyst from May 2011 to April 2012. From May 2012 to October 2021, they worked at Vesalius Biocapital, initially as an Analyst and later as a Principal. Dr. Tian then took on the role of Principal at yabeo from October 2021 to April 2023. Dr. Fei also served as an Investor and Board Member at Dr.Dropin from May 2022 to April 2023. Currently, Dr. Tian holds positions as a Board Member at RoX Health starting from March 2022 and as a Principal at MIG Capital since April 2023. Additionally, they are a Board Member at Temedica starting from December 2023.

Dr. Fei Tian completed their education as follows:

- From 2000 to 2005, they attended Tongji University and obtained a Medical Doctor (MD) degree in Medicine.

- From 2005 to 2008, they pursued a Master's degree in Microbiology and Immunology from Tongji University.

- Finally, from 2008 to 2011, they earned their Doctor of Philosophy (PhD) in Medicine with a focus on Human Biology from Ludwig-Maximilians-Universität München.